111 related articles for article (PubMed ID: 6768062)
1. [Characteristics of the coagulative and immunological properties of fibrinogen degradation products].
Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LN
Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):44-6. PubMed ID: 6768062
[No Abstract] [Full Text] [Related]
2. Biological effects of fibrinogen-fibrin degradation products.
Larrieu MJ; Dray L; Ardaillou N
Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
[No Abstract] [Full Text] [Related]
3. [Comparative study of the properties of a fibrinogen--heparin complex produced in vitro and one isolated from a plasma fraction of fibrinogen degradation products].
Kudriashov BA; Liapina LA; Zhitnikova ES; Kriukova MG
Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (9):58-62. PubMed ID: 497299
[No Abstract] [Full Text] [Related]
4. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
Lab Delo; 1978; (5):259-66. PubMed ID: 79007
[No Abstract] [Full Text] [Related]
5. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood].
Kotschy M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):426-36. PubMed ID: 4121336
[No Abstract] [Full Text] [Related]
6. [Quantitative assay of fibrinogen and fibrin grafts. Simple radial immunodiffusion and electroimmunoassay (author's transl)].
Blatný J; Rozprínová L; Fiserová E; Frágner J
Cas Lek Cesk; 1976 Jul; 115(28):861-4. PubMed ID: 821614
[No Abstract] [Full Text] [Related]
7. Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin.
Mitchell PS; Beller FK
Thromb Diath Haemorrh; 1970 Jun; 23(3):477-85. PubMed ID: 4989113
[No Abstract] [Full Text] [Related]
8. Anticlotting properties of fragments D from human fibrinogen and fibrin.
Haverkate F; Timan G; Nieuwenhuizen W
Eur J Clin Invest; 1979 Aug; 9(4):253-5. PubMed ID: 118016
[TBL] [Abstract][Full Text] [Related]
9. The half-life of plasmic degradation products of human fibrinogen in rabbits.
Ardaillou N; Dray L; Budzynski AZ; Marder VJ; Larrieu MJ
Thromb Haemost; 1977 Apr; 37(2):201-9. PubMed ID: 577624
[TBL] [Abstract][Full Text] [Related]
10. [Studies on coagulation and fibrinolysis. II. Coagulodynamicogram and its applications].
Hu YM; Xue H; Wang KQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982; 4(2):86-91. PubMed ID: 6216014
[No Abstract] [Full Text] [Related]
11. [Quantitative determination of fibrinogen and fibrin degradation products by means of immunodiffusion].
Paradeeva IK; Zhukova IV
Lab Delo; 1979; (10):590-2. PubMed ID: 94124
[No Abstract] [Full Text] [Related]
12. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
Neri Serneri GG; Gensini GF; Abbate R; Favilla S
Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
[No Abstract] [Full Text] [Related]
13. [Effect of exogenous proteinases on blood coagulation factors].
Geĭtman IIa; Kardash BE; Kivman GIa
Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):38-44. PubMed ID: 6757917
[No Abstract] [Full Text] [Related]
14. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
Kolodie L; Detante J; Rachail M
Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
[No Abstract] [Full Text] [Related]
15. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
16. [Quantification of the fibrinogen degradation products FDP-D and FDP-E in blood, using immunoenzyme analysis].
León VJ; León E; López Borrasca A
Sangre (Barc); 1986; 31(1):23-30. PubMed ID: 3085242
[No Abstract] [Full Text] [Related]
17. [Determination of fibrinogen degradation products by rocket immunoelectrophoresis].
Zozuliakova SV; Podosinnikov IS
Lab Delo; 1981; (7):409-11. PubMed ID: 6167774
[No Abstract] [Full Text] [Related]
18. Detection of anticoagulant activities of isolated canine fibrinogen degradation products X, Y, D and E using resonance thrombography.
Mischke R; Wolling H; Nolte I
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):81-8. PubMed ID: 15166948
[TBL] [Abstract][Full Text] [Related]
19. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
Dempfle CE; Keller A; Argirion S; Heene DL
Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent nature of the interaction of fibrinogen-degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations [proceedings].
Forster C; Mohan J; Whalley ET
Br J Pharmacol; 1980 Jan; 68(1):151P. PubMed ID: 7357163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
